Naotoshi Sugimoto Selected Research

Collagen

1/2017	Use of αv Integrin Linked to GFP to Image Molecular Dynamics in Trafficking Cancer-Cell Emboli.
8/2013	Real-time imaging of αv integrin molecular dynamics in osteosarcoma cells in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Naotoshi Sugimoto Research Topics

Disease

35	Neoplasms (Cancer) 01/2024 - 06/2002
31	Stomach Neoplasms (Stomach Cancer) 05/2024 - 11/2004
21	Colorectal Neoplasms (Colorectal Cancer) 01/2024 - 10/2012
10	Osteosarcoma (Osteogenic Sarcoma) 01/2017 - 10/2009
9	Neoplasm Metastasis (Metastasis) 11/2023 - 10/2009
9	Neutropenia 01/2023 - 01/2008
8	Adenocarcinoma 01/2023 - 10/2012
8	Inflammation (Inflammations) 08/2019 - 06/2002
5	Hemolytic-Uremic Syndrome 12/2021 - 09/2016
5	Glioblastoma (Glioblastoma Multiforme) 08/2019 - 05/2010
4	Disease Progression 01/2023 - 10/2014
4	Anemia 03/2020 - 12/2013
4	Glioma (Gliomas) 01/2014 - 05/2010
3	Brain Neoplasms (Brain Tumor) 11/2023 - 03/2013
3	Colonic Neoplasms (Colon Cancer) 09/2022 - 01/2018
3	Body Weight (Weight, Body) 05/2022 - 05/2019
3	Fatigue 12/2018 - 10/2014
3	Hypoxia (Hypoxemia) 12/2017 - 06/2011
3	Hypothermia 12/2011 - 10/2004
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 10/2023 - 05/2013
2	Hemorrhage 04/2021 - 01/2017
2	Infections 01/2020 - 09/2016
2	Breast Neoplasms (Breast Cancer) 03/2019 - 01/2017
2	Hyponatremia 12/2018 - 07/2016
2	Anorexia 12/2018 - 12/2013
2	Brain Diseases (Brain Disorder) 12/2017 - 09/2016
2	Fibrosis (Cirrhosis) 01/2017 - 02/2010
2	Embolism (Embolus) 01/2017 - 08/2016
2	Fever (Fevers) 10/2013 - 08/2003
2	Esophageal Neoplasms (Esophageal Cancer) 06/2012 - 01/2010
2	Atherosclerosis 11/2010 - 03/2004
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 05/2024

Drug/Important Bio-Agent (IBA)

15	Irinotecan (Camptosar)FDA LinkGeneric 01/2023 - 11/2004
12	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2022 - 10/2012
10	trifluridine tipiracil drug combinationIBA 01/2024 - 10/2012
10	Cisplatin (Platino)FDA LinkGeneric 08/2022 - 12/2013
10	S-1 plus cisplatinIBA 10/2021 - 01/2016
8	Biomarkers (Surrogate Marker)IBA 05/2024 - 04/2015
8	Bevacizumab (Avastin)FDA Link 01/2024 - 11/2015
8	Proteins (Proteins, Gene)FDA Link 11/2022 - 05/2010
8	Paclitaxel (Taxol)FDA LinkGeneric 10/2021 - 01/2008
7	IntegrinsIBA 01/2017 - 08/2013
6	PlatinumIBA 04/2024 - 12/2013
6	regorafenibIBA 04/2021 - 01/2018
6	Green Fluorescent ProteinsIBA 01/2017 - 08/2013
4	NivolumabIBA 01/2024 - 01/2019
4	Capecitabine (Xeloda)FDA Link 09/2020 - 02/2015
3	trastuzumab deruxtecanIBA 05/2024 - 01/2020
3	pembrolizumabIBA 09/2023 - 08/2022
3	TheobromineIBA 05/2022 - 01/2014
3	RamucirumabIBA 01/2021 - 10/2014
3	Fluorouracil (Carac)FDA LinkGeneric 11/2019 - 01/2016
3	CannabinoidsIBA 08/2019 - 10/2012
3	Caffeine (No Doz)FDA LinkGeneric 11/2013 - 08/2011
3	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 11/2010 - 08/2003
3	Sphingosine-1-Phosphate ReceptorsIBA 11/2010 - 02/2010
2	ErbB Receptors (EGF Receptor)IBA 05/2024 - 01/2023
2	B7-H1 AntigenIBA 09/2023 - 08/2022
2	human ERBB2 proteinIBA 01/2023 - 08/2022
2	Messenger RNA (mRNA)IBA 11/2022 - 08/2019
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2022 - 08/2011
2	Panitumumab (Vectibix)FDA Link 09/2022 - 01/2020
2	Cetuximab (Erbitux)FDA Link 09/2022 - 01/2020
2	Adenosine Monophosphate (AMP)IBA 05/2022 - 03/2013
2	PlasticsIBA 05/2022 - 08/2014
2	LipidsIBA 05/2022 - 01/2009
2	EnzymesIBA 05/2022 - 12/2017
2	Indicators and Reagents (Reagents)IBA 12/2021 - 12/2017
2	Trastuzumab (Herceptin)FDA Link 01/2020 - 01/2018
2	afliberceptIBA 11/2019 - 03/2019
2	EndocannabinoidsIBA 08/2019 - 12/2017
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 08/2019 - 10/2012
2	InterleukinsIBA 04/2019 - 05/2013
2	Interleukin-33IBA 04/2019 - 05/2013
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 12/2017 - 10/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2017 - 05/2010
2	Leucovorin (Folinic Acid)FDA Link 01/2017 - 01/2016
2	CollagenIBA 01/2017 - 08/2013
2	echistatinIBA 12/2016 - 01/2016
2	DisintegrinsIBA 12/2016 - 01/2016
2	XELOXIBA 11/2015 - 02/2015
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2014 - 03/2013
2	TOR Serine-Threonine KinasesIBA 01/2014 - 09/2012
2	Mitogen-Activated Protein KinasesIBA 03/2013 - 09/2012
2	Small Interfering RNA (siRNA)IBA 08/2011 - 05/2010
2	LysophospholipidsIBA 06/2006 - 06/2002
2	Taxoids (Taxanes)IBA 06/2006 - 11/2004
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 05/2024
1	taxaneIBA 04/2024
1	eribulin FDA Link 01/2024
1	Tumor Biomarkers (Tumor Markers)IBA 01/2024
1	Complement System Proteins (Complement)IBA 01/2024
1	Cell-Free Nucleic AcidsIBA 01/2024

Therapy/Procedure

28	Drug Therapy (Chemotherapy) 11/2023 - 11/2004
22	Therapeutics 11/2023 - 03/2009
4	Adjuvant Chemotherapy 10/2021 - 01/2019
3	Combination Drug Therapy (Combination Chemotherapy) 10/2021 - 06/2006
2	Radiotherapy 01/2019 - 01/2012
2	Chemoradiotherapy 06/2012 - 01/2010
2	Injections 05/2010 - 10/2004